ES | EN

Your shopping cart

Amount

Total (VAT incl.)

VAT (21%)
Total
You have not added any reports to the cart yet.
Request reports
If you prefer to place your order via e-mail
contact us at: digital@azierta.com

Industrial area

Risk analysis of Nitrosamines impurities

  • In September 2019, the CMDh published the information note "Information on Nitrosamines for Drug Authorisation Holders". The document of the EMA/511347/2019, asks the MAHs for a risk assessment of the presence of nitrosamines in all chemically synthesised human medicines.
  • The risk assessment for human chemical medicines should be completed by 31 March, 2021 and by 1 July 2021 for biological medicines.
  • At Azierta, we offer a global service that covers the risk analysis, analytical phase and includes regulatory support with variation management.
nitrosamine-impurities

We have a multidisciplinary team, with great experience implementing the ICH Q9 quality management regulations and in the evaluation and control of mutagenic impurities according to ICH M7

1. Analysis and prioritization

  • Prioritization of products taking into account MDD, treatment duration, therapeutic indication, and product order based on the number of units sold.

2. Risk assessment

  • Risk assessment of drugs containing chemically synthesized APIs according to ICH guideline Q9.

3. Confirmation tests

  • If a risk of nitrosamines is detected, confirmatory testing is required using equipment of high sensitivity and specificity that has been validated.
  • These impurities can be quantified by mass detectors associated with liquid (LC/MS) or gas chromatographs (GC/MS).
  • TACs should report immediately if testing confirms the presence of nitrosamines.

4. Regulatory variations

  • Request for modification, introducing the necessary changes, such as modification of the manufacturing process or changes in the product specifications.


Eurotox

We have a specialized area in toxicological support composed of a multidisciplinary team of expert toxicologists accredited by AETOX, EUROTOX and ERT.

Leading innovation in pharma & health

100 professionals

Over 100 professionals

500 clients

Over 500 clients

9 year experience

9 years of experience

Innovation

Leading innovation

Client oriented

100% client oriented

DO YOU HAVE ANY DOUBTS?

We help you in everything you need. Contact us by filling out the form or book an appointment for a video call with one of our experts.

We use "cookies" to improve your experience on our site. Cookies enable us to tailor messages and display ads to your interests. They also help us understand how our site is being used. By continuing to use our site you consent to use our cookies.

We are at your complete disposal for any inquiry

Thank you for getting in touch! We will contact you as soon as possible to help you out
There has been an error while submitting your form, please try again, or call us at 912 77 10 76

How can we
help you?

    There was an error submitting your details, please try again.
    Azierta

    Your request has been submitted
    correctly

    Our team is working
    to get in contact you
    as soon as possible

    Thank you
    very much!